6988.T
Latest Trade
9,030.00JPYChange
-80.00(-0.88%)Volume
623,100Today's Range
-
9,060.0052 Week Range
-
10,170.00As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 9,110.00 |
|---|---|
Open | 9,020.00 |
Volume | 623,100 |
3M AVG Volume | 12.18 |
Today's High | 9,060.00 |
Today's Low | 8,860.00 |
52 Week High | 10,170.00 |
52 Week Low | 4,115.00 |
Shares Out (MIL) | 147.97 |
Market Cap (MIL) | 1,446,289.00 |
Forward P/E | 22.97 |
Dividend (Yield %) | 2.20 |
Nitto Denko to transfer partial automobile processed goods business to wholly owned unit NISSHO
Nitto Denko completes share repurchase
R&I affirms Nitto Denko's rating at "AA-" and says stable outlook -R&I
NITTO DENKO CORPORATION is a Japan-based company mainly engaged in the industrial tape business, the optronics business and the life science business. The Company operates in three business segments. The Industrial Tapes segment is engaged in the manufacture and sale of basic functional materials such as bonding materials and protective materials, as well as automotive materials. The Optronics segment is engaged in the manufacture and sale of information functional materials, printed circuits and process materials. The Life Science segment is engaged in the manufacture and sale of medical related materials. The Company is also engaged in the manufacture and sale of polymer separation membranes and other products.
Industry
Semiconductors
Contact Info
33F, GRAND FRONT OSAKA Tower A
4-20, Ofuka-cho
Kita-ku
OSAKA-SHI, OSK
530-0011
Japan
+81.6.76322101
https://www.nitto.com/jp/ja/Executive Leadership
Hideo Takasaki
President, Chief Executive Officer, Chief Operating Officer, Representative Director
Yasuhiro Iseyama
Chief Financial Officer, Senior Executive Officer, Director
Yosuke Miki
Chief Technology Officer, Managing Executive Officer, Manager of Companywide Technology, Manager of ICT Business Unit, Director
Toshihiko Omote
Senior Managing Executive Officer
Michio Yoshimoto
Senior Managing Executive Officer
Price To Earnings (TTM) | 22.79 |
|---|---|
Price To Sales (TTM) | 1.96 |
Price To Book (MRQ) | 1.98 |
Price To Cash Flow (TTM) | 13.40 |
Total Debt To Equity (MRQ) | 2.53 |
LT Debt To Equity (MRQ) | 2.51 |
Return on Investment (TTM) | 7.79 |
Return on Equity (TTM) | 6.44 |
* CAGE BIO INC. - ANNOUNCED RESEARCH AND DEVELOPMENT AGREEMENT WITH NITTO DENKO CORPORATION FOR TRANSDERMAL FORMULATION OF UNDISCLOSED MOLECULES Source text for Eikon: Further company coverage:
* Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA-" -R&I
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.